Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04358458
Title First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Age Groups: senior | adult
Covered Countries USA | NLD | FRA | ESP | BEL

No variant requirements are available.